Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC14207GW791343 HClCAS: 309712-55-8
GW791343 HCl 是一种有效的人 P2X7 受体负变构调节剂(表现出物种特异性活性),对人 P2X7 受体产生非竞争性拮抗作用,pIC50 为 6.9-7.2。
- GC14216Chlorpromazine HClCAS: 69-09-0纯度: >99.50%
Chlorpromazine HCl是一种口服有效的、可透过血脑屏障的吩噻嗪类抗精神病药,能够有效抑制D2多巴胺受体和5-HT 2A ,具有很强的镇静作用。
- GC14261Diclofenac SodiumCAS: 15307-79-6纯度: >99.50%
Diclofenac Sodium是一种强效的非选择性环氧化酶(COX)抑制剂,在CHO细胞中对人源COX-1和COX-2的IC₅₀值分别为4nM和1.3nM;对羊源COX-1和COX-2的IC₅₀值分别为5.1μM和0.84μM。
- GC14289Fasudil (HA-1077) HClCAS: 105628-07-7纯度: >99.50% / >98.00%
Fasudil (HA-1077) HCl(法舒地尔;HA-1077;AT877)是一种非特异性RhoA/ROCK抑制剂,对ROCK1的K i 为0.33μM,IC 50 为0.158μM,对ROCK2和PKA、PKC、PKG的IC 50 分别为4.58μM、12.30μM、1.650μM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14204 | Biapenem | 120410-24-4 | >98.00% | |
A broad-spectrum β-lactam antibiotic | ||||
| GC14207 | GW791343 HCl | 309712-55-8 | - | |
GW791343 HCl 是一种有效的人 P2X7 受体负变构调节剂(表现出物种特异性活性),对人 P2X7 受体产生非竞争性拮抗作用,pIC50 为 6.9-7.2。 | ||||
| GC14214 | BMS-777607 | 1025720-94-8 | >99.00% | |
BMS-777607 是一种泛 TAM 抑制剂,对不同类型的癌症显示出抗肿瘤活性。 | ||||
| GC14215 | Cevimeline | 107233-08-9 | >98.00% | |
Cevimeline是一种强效的直接作用muscarinic受体激动剂,具有口服生物利用度。 | ||||
| GC14216 | Chlorpromazine HCl | 69-09-0 | >99.50% | |
Chlorpromazine HCl是一种口服有效的、可透过血脑屏障的吩噻嗪类抗精神病药,能够有效抑制D2多巴胺受体和5-HT 2A ,具有很强的镇静作用。 | ||||
| GC14220 | Scopine | 498-45-3 | >98.00% | |
A metabolite of scopolamine | ||||
| GC14226 | Methazolamide | 554-57-4 | >98.00% | |
A carbonic anhydrase inhibitor | ||||
| GC14233 | BIO-acetoxime | 667463-85-6 | >98.00% | |
A potent, selective inhibitor of GSK3α/β | ||||
| GC14234 | PF-477736 | 952021-60-2 | >99.00% | |
A selective inhibitor of checkpoint kinase 1 | ||||
| GC14237 | Nilotinib monohydrochloride monohydrate | 923288-90-8 | >99.50% | |
A Bcr-Abl inhibitor | ||||
| GC14238 | Brivanib Alaninate (BMS-582664) | 649735-63-7 | >99.00% | |
A prodrug form of brivanib | ||||
| GC14243 | Resminostat hydrochloride | 1187075-34-8 | >99.00% | |
An orally bioavailable HDAC inhibitor | ||||
| GC14245 | ZM 39923 HCl | 1021868-92-7 | >99.50% | |
A potent inhibitor of JAK3 | ||||
| GC14250 | Bepotastine Besilate | 190786-44-8 | >99.50% | |
A histamine H 1 receptor antagonist | ||||
| GC14252 | (-)-Stepholidine | 16562-13-3 | - | |
A dopamine receptor antagonist and 5-HT 1A partial agonist | ||||
| GC14256 | Tivantinib (ARQ 197) | 905854-02-6 | >99.50% | |
An inhibitor of c-Met | ||||
| GC14261 | Diclofenac Sodium | 15307-79-6 | >99.50% | |
Diclofenac Sodium是一种强效的非选择性环氧化酶(COX)抑制剂,在CHO细胞中对人源COX-1和COX-2的IC₅₀值分别为4nM和1.3nM;对羊源COX-1和COX-2的IC₅₀值分别为5.1μM和0.84μM。 | ||||
| GC14262 | Desvenlafaxine Succinate | 386750-22-7 | >99.50% | |
An active metabolite of venlafaxine | ||||
| GC14269 | Cobicistat (GS-9350) | 1004316-88-4 | >98.00% | |
An inhibitor of CYP3A | ||||
| GC14270 | Delafloxacin meglumine | 352458-37-8 | >99.00% | |
A fluoroquinolone antibiotic | ||||
| GC14285 | RGFP966 | 1357389-11-7 | >99.50% / >98.00% | |
RGFP966是一种N-(o-aminophenyl)carboxamide HDAC抑制剂,对HDAC3的IC50为0.08 μM,是一类针对HDAC3的慢开/慢关竞争性紧密结合抑制剂。 | ||||
| GC14289 | Fasudil (HA-1077) HCl | 105628-07-7 | >99.50% / >98.00% | |
Fasudil (HA-1077) HCl(法舒地尔;HA-1077;AT877)是一种非特异性RhoA/ROCK抑制剂,对ROCK1的K i 为0.33μM,IC 50 为0.158μM,对ROCK2和PKA、PKC、PKG的IC 50 分别为4.58μM、12.30μM、1.650μM。 | ||||
| GC14295 | Gefitinib hydrochloride | 184475-55-6 | >99.00% | |
An EGFR inhibitor | ||||
| GC14306 | 3F8 | 159109-11-2 | - | |
3F8 是一种有效且选择性的 GSK-3β 抑制剂,可用作 GSK3 相关疾病的新试剂和潜在治疗候选物。 | ||||
